A nanocarrier system that potentiates the effect of miconazole within different interkingdom biofilms

References

• Frencken JE, Sharma P, Stenhouse L, et al. Global epidemiology of dental caries and severe periodontitis - a comprehensive review. J Clin Periodontol. 2017;44(Suppl 18):S94–S105.
   PubMedGoogle Scholar
• Lourenco AG, Ribeiro AERA, Nakao C, et al. Oral Candida spp carriage and periodontal diseases in HIV-infected patients in Ribeirao Preto, Brazil. Rev Inst Med Trop Sao Paulo. 2017;59:e29.
   Web of Science ®Google Scholar
• Nakajima M, Umezaki Y, Takeda S, et al. Association between oral candidiasis and bacterial pneumonia: A retrospective study. Oral Dis. 2020;26(1):234–237.
   Google Scholar
• Ramage G, O’Donnell L, Sherry L, et al. Impact of frequency of denture cleaning on microbial and clinical parameters - a bench to chairside approach. J Oral Microbiol. 2019;11(1):1538437.
   PubMed Web of Science ®Google Scholar
• Brown JL, Johnston W, Delaney C, et al. Polymicrobial oral biofilm models: simplifying the complex. J Med Microbiol. 2019;68(11):1573–15.
   PubMed Web of Science ®Google Scholar
• Delaney C, Kean R, Short B, et al. Fungi at the Scene of the Crime: innocent Bystanders or Accomplices in Oral Infections? Curr Clin Microbiol Rep. 2018;5(3):190–200.
   Web of Science ®Google Scholar
• Koo H, Andes DR, Krysan DJ. Candida-streptococcal interactions in biofilm-associated oral diseases. PLoS Pathog. 2018;14(12):e1007342.
   PubMed Web of Science ®Google Scholar
• Nobbs AH, Jenkinson HF. Interkingdom networking within the oral microbiome. Microbes Infect. 2015;17(7):484–492.
   PubMed Web of Science ®Google Scholar
• Xu H, Jenkinson HF, Dongari-Bagtzoglou A. Innocent until proven guilty: mechanisms and roles of Streptococcus-Candida interactions in oral health and disease. Mol Oral Microbiol. 2014;29(3):99–116.
   PubMed Web of Science ®Google Scholar
• Kean R, Rajendran R, Haggarty J, et al. Candida albicans Mycofilms Support Staphylococcus aureus Colonization and Enhances Miconazole Resistance in Dual-Species Interactions. Front Microbiol. 2017;8:258.
   PubMed Web of Science ®Google Scholar
• Sztukowska MN, Dutton LC, Delaney C, et al. Community Development between Porphyromonas gingivalis and Candida albicans Mediated by InlJ and Als3. mBio. 2018;9(2):e00202-18.
   Google Scholar
• Wu T, Cen L, Kaplan C, et al. Cellular Components Mediating Coadherence of Candida albicans and Fusobacterium nucleatum. J Dent Res. 2015;94(10):1432–1438.
   Web of Science ®Google Scholar
• Wistrand-Yuen E, Knopp M, Hjort K, et al. Evolution of high-level resistance during low-level antibiotic exposure. Nat Commun. 2018;9(1):1599.
   PubMedGoogle Scholar
• Aslani N, Abastabar M, Hedayati MT, et al. Molecular identification and antifungal susceptibility testing of Candida species isolated from dental plaques. J Mycol Med. 2018;28(3):433–436.
   Web of Science ®Google Scholar
• Sardi JC, Almeida AM, Mendes Giannini MJ. New antimicrobial therapies used against fungi present in subgingival sites–a brief review. Arch Oral Biol. 2011;56(10):951–959.
   Web of Science ®Google Scholar
• Nenoff P, Koch D, Krüger C, et al. New insights on the antibacterial efficacy of miconazole in vitro. Mycoses. 2017;60(8):552–557.
   Web of Science ®Google Scholar
• Miranda-Cadena K, Marcos-Arias C, Mateo E, et al. Prevalence and antifungal susceptibility profiles of Candida glabrata, Candida parapsilosis and their close-related species in oral candidiasis. Arch Oral Biol. 2018;95:100–107.
   PubMed Web of Science ®Google Scholar
• Cross EW, Park S, Perlin DS. Cross-Resistance of clinical isolates of Candida albicans and Candida glabrata to over-the-counter azoles used in the treatment of vaginitis. Microb Drug Resist. 2000;6(2):155–161.
   PubMed Web of Science ®Google Scholar
• Müller FM, Weig M, Peter J, Walsh TJ. Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis. J Antimicrob Chemother. 2000;46(2):338‐340.
   Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16(1):71.
   PubMed Web of Science ®Google Scholar
• Arias LS, Hardick J, Barnes M, et al. Iron Oxide Nanoparticles for Biomedical Applications: A Perspective on Synthesis, Drugs, Antimicrobial Activity, and Toxicity. Antibiotics (Basel). 2018;7(2). DOI:10.3390/antibiotics7030077.
   Web of Science ®Google Scholar
• Vieira APM, Arias LS, de Souza Neto FN, et al. Antibiofilm effect of chlorhexidine-carrier nanosystem based on iron oxide magnetic nanoparticles and chitosan. Colloids Surf B Biointerfaces. 2019;174:224–231.
   PubMed Web of Science ®Google Scholar
• Nehra P, Chauhan RP, Garg N, et al. Antibacterial and antifungal activity of chitosan coated iron oxide nanoparticles. Br J Biomed Sci. 2018;75(1):13–18.
   PubMed Web of Science ®Google Scholar
• Arias LS, Pessan JP, de Souza Neto FN, et al. Novel nanocarrier of miconazole based on chitosan-coated iron oxide nanoparticles as a nanotherapy to fight Candida biofilms. Colloids Surf B Biointerfaces. 2020:111080. DOI:10.1016/j.colsurfb.2020.111080.
   Web of Science ®Google Scholar
• Allkja J, Bjarnsholt T, Coenye T, et al. Minimum information guideline for spectrophotometric and fluorometric methods to assess biofilm formation in microplates. Biofilm. 2020;2. DOI:10.1016/j.bioflm.2019.100010.
   Google Scholar
• Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. J Hyg (Lond). 1938;38(6):732–749.
   PubMedGoogle Scholar
• Zhou Y, Millhouse E, Shaw T, et al. Evaluating Streptococcus mutans Strain Dependent Characteristics in a Polymicrobial Biofilm Community. Front Microbiol. 2018;9:1498.
   Web of Science ®Google Scholar
• Brown JL, Johnston W, Delaney C, et al. Biofilm-stimulated epithelium modulates the inflammatory responses in co-cultured immune cells. Sci Rep. 2019;9(1):15779.
   PubMedGoogle Scholar
• Montelongo-Jauregui D, Srinivasan A, Ramasubramanian AK, et al. An In Vitro Model for Oral Mixed Biofilms of Candida albicans and Streptococcus gordonii in Synthetic Saliva. Front Microbiol. 2016;7:686.
   PubMed Web of Science ®Google Scholar
• Sherry L, Lappin G, O’Donnell LE, et al. Viable Compositional Analysis of an Eleven Species Oral Polymicrobial Biofilm. Front Microbiol. 2016;7:912.
   PubMed Web of Science ®Google Scholar
• Erlandsen SL, Kristich CJ, Dunny GM, et al. High-resolution visualization of the microbial glycocalyx with low-voltage scanning electron microscopy: dependence on cationic dyes. J Histochem Cytochem. 2004;52(11):1427–1435.
   PubMed Web of Science ®Google Scholar
• Tunney MM, Patrick S, Gorman SP, et al. Improved detection of infection in hip replacements. A currently underestimated problem. J Bone Joint Surg Br. 1998;80(4):568–572.
   PubMedGoogle Scholar
• Allison DL, Willems HME, Jayatilake JAMS et al. Candida-Bacteria Interactions: their Impact on Human Disease. Microbiol Spectr. 2016;4(3).
   Web of Science ®Google Scholar
• Ramage G, Rajendran R, Sherry L, et al. Fungal biofilm resistance. Int J Microbiol. 2012;2012:528521.
   PubMedGoogle Scholar
• Garcia-Cuesta C, Sarrion-Perez MG., Bagan JV. Current treatment of oral candidiasis: A literature review. J Clin Exp Dent. 2014;6(5):e576–82.
   PubMedGoogle Scholar
• Brincker H. Prophylactic treatment with miconazole in patients highly predisposed to fungal infection. A placebo-controlled double-blind study. Acta Med Scand. 1978;204(1–2):123–128.
   Google Scholar
• Delattin N, Cammue BP, Thevissen K. Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Future Med Chem. 2014;6(1):77–90.
   PubMed Web of Science ®Google Scholar
• Lou MM, Zhu B, Muhammad I, et al. Antibacterial activity and mechanism of action of chitosan solutions against apricot fruit rot pathogen Burkholderia seminalis. Carbohydr Res. 2011;346(11):1294–1301.
   Web of Science ®Google Scholar
• Rabea EI, Badawy ME-T, Stevens CV, et al. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules. 2003;4(6):1457–1465.
   PubMed Web of Science ®Google Scholar
• Rajkumar S, Prabaharan M. Multi-functional nanocarriers based on iron oxide nanoparticles conjugated with doxorubicin, poly(ethylene glycol) and folic acid as theranostics for cancer therapy. Colloids Surf B Biointerfaces. 2018;170:529–537.
   PubMed Web of Science ®Google Scholar
• Harriott MM, Noverr MC. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother. 2009;53(9):3914–3922.
   PubMed Web of Science ®Google Scholar
• Xu H, Sobue T, Thompson A, et al. Streptococcal co-infection augments Candida pathogenicity by amplifying the mucosal inflammatory response. Cell Microbiol. 2014;16(2):214–231. .
   Web of Science ®Google Scholar
• Mukaremera L, Lee KK, Mora-Montes HM, et al. Candida albicans Yeast, Pseudohyphal, and Hyphal Morphogenesis Differentially Affects Immune Recognition. Front Immunol. 2017;8:629.
   PubMed Web of Science ®Google Scholar
• Kim D, Liu Y, Benhamou RI, et al. Bacterial-derived exopolysaccharides enhance antifungal drug tolerance in a cross-kingdom oral biofilm. Isme J. 2018;12(6):1427–1442.
   Web of Science ®Google Scholar